NCCN Guidelines® Insights - Hodgkin Lymphoma, Version 2.2022
Hodgkin lymphoma (HL) is an uncommon malignancy of B-cell origin. Classical HL (cHL) and nodular lymphocyte–predominant HL are the 2 main types of HL.
Category
  • Hodgkin Lymphoma
Format
  • Monograph/Journal Supplement
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Mycosis Fungoides and Sézary Syndrome: Overview of Systemic Therapy
Pharmacists should be aware of the treatment recommendations for this rare disease type so they can support patients as well as the health care team in making informed treatment decisions. It is also important to be aware of the potential adverse events that can occur with these therapies since pharmacists frequently provide patient education and monitoring related to this in order to avoid severe complications and maximize treatment outcomes.
Category
  • T-Cell Lymphomas
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
April 2022 BCOP Test - Mycosis Fungoides and Sézary Syndrome: Overview of Systemic Therapy
The test is available for an additional fee of $50. Each activity is this series is worth 1 hour of BCOP credit. Save $10 per test by purchasing the 12-test bundle!
Category
Format
Credits
NCCN Guidelines® Insights - Hematopoietic Growth Factors, Version 1.2022
The NCCN Guidelines for Hematopoietic Growth Factors provide recommendations for the appropriate use of growth factors in the clinical management of febrile neutropenia (FN), chemotherapy-induced thrombocytopenia (CIT), and chemotherapy-induced anemia (CIA).
Category
  • Myeloid Growth Factors
Format
  • Monograph/Journal Supplement
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Emerging Treatment Landscape of Targeted Therapies in Hematologic Malignancies
It is integral for nurses to have current knowledge of new targeted therapies in hematologic malignancies to understand mechanisms of actions and side effect profiles to support optimal patient outcomes.
Category
  • Hematologic Malignancies
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Desensitization Protocols in the Outpatient Setting
Continued education in outpatient desensitization will allow institutions to adapt their protocols and adjust to the ever-changing landscape of cancer care.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Updates in the Treatment of Lymphoma
This presentation will help guide nurses in the use of novel agents, the timing of those agents, and the treatment when a patient has progressed after first-line therapy. New agents will be discussed, including administration information, side effects, and helpful patient education information for nursing.
Category
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Toxicities of CAR T-Cell Therapy: Beyond CRS and Neurotoxicity
The information presented in this talk will address the long-term effects of CAR T-cell therapy, including HLH/MAS, B-cell aplasia, and prolonged cytopenias. Nurses will learn how to recognize signs/symptoms of these effects and how to manage them in order to educate patients and provide ideal care to patients undergoing CAR T-cell therapy.
Category
  • Acute Lymphoblastic Leukemia
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Updates in the Treatment of CNS Cancers
The involvement of an interdisciplinary team in the treatment of patients with CNS cancers is a key factor for appropriate management. Integrated histopathologic and molecular characterization of brain tumors such as gliomas should be standard practice, and research in this area is ongoing.
Category
  • CNS Cancers
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Communicating an Adult Diagnosis of Cancer to Children
Nurses are a valuable resource to support and guide parents in communicating their cancer diagnosis with their children. This can result in improved relationships, better coping and less stress on the parent. With the proper training, nurses can facilitate this process while supporting and empowering parents in sharing this personal experience with their children.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation

Pages